• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BCAT1 是 IDH1 野生型胶质母细胞瘤患者预后预测的新 MRI 相关生物标志物。

BCAT1 is a New MR Imaging-related Biomarker for Prognosis Prediction in IDH1-wildtype Glioblastoma Patients.

机构信息

Department of Radiology, Seoul National University Hospital, Seoul, Korea.

Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul, Korea.

出版信息

Sci Rep. 2017 Dec 18;7(1):17740. doi: 10.1038/s41598-017-17062-1.

DOI:10.1038/s41598-017-17062-1
PMID:29255149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5735129/
Abstract

Isocitrate dehydrogenase 1 (IDH1)-wildtype glioblastoma (GBM) has found to be accompanied with increased expression of branched-chain amino acid trasaminase1 (BCAT1), which is associated with tumor growth and disease progression. In this retrospective study, quantitative RT-PCR, immunohistochemistry, and western blot were performed with GBM patient tissues to evaluate the BCAT1 level. Quantitative MR imaging parameters were evaluated from DSC perfusion imaging, DWI, contrast-enhanced T1WI and FLAIR imaging using a 3T MR scanner. The level of BCAT1 was significantly higher in IDH1-wildtype patients than in IDH1-mutant patients obtained in immunohistochemistry and western blot. The BCAT1 level was significantly correlated with the mean and 95 percentile-normalized CBV as well as the mean ADC based on FLAIR images. In addition, the 95 percentile-normalized CBV from CE T1WI also had a significant correlation with the BCAT1 level. Moreover, the median PFS in patients with BCAT1 expression <100 was longer than in those with BCAT1 expression ≥100. Taken together, we found that a high BCAT1 level is correlated with high CBV and a low ADC value as well as the poor prognosis of BCAT1 expression is related to the aggressive nature of GBM.

摘要

异柠檬酸脱氢酶 1(IDH1)-野生型脑胶质瘤(GBM)被发现伴随着支链氨基酸转氨酶 1(BCAT1)的表达增加,这与肿瘤生长和疾病进展有关。在这项回顾性研究中,使用 GBM 患者组织进行了定量 RT-PCR、免疫组织化学和 Western blot 检测,以评估 BCAT1 水平。使用 3T MR 扫描仪对 DSC 灌注成像、DWI、增强 T1WI 和 FLAIR 成像的定量 MR 成像参数进行了评估。在免疫组织化学和 Western blot 中,IDH1 野生型患者的 BCAT1 水平明显高于 IDH1 突变型患者。BCAT1 水平与基于 FLAIR 图像的平均和 95 百分位归一化 CBV 以及平均 ADC 显著相关。此外,CE T1WI 的 95 百分位归一化 CBV 与 BCAT1 水平也有显著相关性。此外,BCAT1 表达<100 的患者的中位 PFS 长于 BCAT1 表达≥100 的患者。综上所述,我们发现高 BCAT1 水平与高 CBV 和低 ADC 值相关,BCAT1 表达不良的预后与 GBM 的侵袭性有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fab/5735129/96ccb0494da4/41598_2017_17062_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fab/5735129/2a9ac6fc44d5/41598_2017_17062_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fab/5735129/596162509842/41598_2017_17062_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fab/5735129/d6ccb1478e47/41598_2017_17062_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fab/5735129/7bea0af29dca/41598_2017_17062_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fab/5735129/96ccb0494da4/41598_2017_17062_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fab/5735129/2a9ac6fc44d5/41598_2017_17062_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fab/5735129/596162509842/41598_2017_17062_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fab/5735129/d6ccb1478e47/41598_2017_17062_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fab/5735129/7bea0af29dca/41598_2017_17062_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fab/5735129/96ccb0494da4/41598_2017_17062_Fig5_HTML.jpg

相似文献

1
BCAT1 is a New MR Imaging-related Biomarker for Prognosis Prediction in IDH1-wildtype Glioblastoma Patients.BCAT1 是 IDH1 野生型胶质母细胞瘤患者预后预测的新 MRI 相关生物标志物。
Sci Rep. 2017 Dec 18;7(1):17740. doi: 10.1038/s41598-017-17062-1.
2
Assessment of bevacizumab resistance increased by expression of BCAT1 in IDH1 wild-type glioblastoma: application of DSC perfusion MR imaging.IDH1野生型胶质母细胞瘤中BCAT1表达增加对贝伐单抗耐药性的评估:DSC灌注磁共振成像的应用
Oncotarget. 2016 Oct 25;7(43):69606-69615. doi: 10.18632/oncotarget.11901.
3
Enrichment of branched chain amino acid transaminase 1 correlates with multiple biological processes and contributes to poor survival of IDH1 wild-type gliomas.支链氨基酸转氨酶 1 的富集与多种生物学过程相关,并且与 IDH1 野生型脑胶质瘤患者的不良预后相关。
Aging (Albany NY). 2021 Jan 20;13(3):3645-3660. doi: 10.18632/aging.202328.
4
BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1.BCAT1 通过代谢野生型 IDH1 的氨基酸促进胶质瘤细胞增殖。
Nat Med. 2013 Jul;19(7):901-908. doi: 10.1038/nm.3217. Epub 2013 Jun 23.
5
Hyperpolarized [1-13C] glutamate: a metabolic imaging biomarker of IDH1 mutational status in glioma.超极化[1-13C]谷氨酸:胶质瘤中异柠檬酸脱氢酶1(IDH1)突变状态的代谢成像生物标志物
Cancer Res. 2014 Aug 15;74(16):4247-57. doi: 10.1158/0008-5472.CAN-14-0680. Epub 2014 May 29.
6
Increased RLIP76 expression in IDH1 wild‑type glioblastoma multiforme is associated with worse prognosis.IDH1 野生型胶质母细胞瘤中 RLIP76 表达增加与预后不良相关。
Oncol Rep. 2020 Jan;43(1):188-200. doi: 10.3892/or.2019.7394. Epub 2019 Oct 30.
7
MR Imaging-Based Analysis of Glioblastoma Multiforme: Estimation of IDH1 Mutation Status.基于磁共振成像的多形性胶质母细胞瘤分析:异柠檬酸脱氢酶1(IDH1)突变状态的评估
AJNR Am J Neuroradiol. 2016 Jan;37(1):58-65. doi: 10.3174/ajnr.A4491. Epub 2015 Sep 24.
8
Prediction of IDH1 Mutation Status in Glioblastoma Using Machine Learning Technique Based on Quantitative Radiomic Data.基于定量放射组学数据的机器学习技术预测胶质母细胞瘤 IDH1 突变状态。
World Neurosurg. 2019 May;125:e688-e696. doi: 10.1016/j.wneu.2019.01.157. Epub 2019 Feb 5.
9
Absence of IDH1-R132H mutation predicts rapid progression of nonenhancing diffuse glioma in older adults.IDH1-R132H 突变缺失预示着老年患者非增强弥漫性胶质瘤的快速进展。
Ann Diagn Pathol. 2012 Jun;16(3):161-70. doi: 10.1016/j.anndiagpath.2011.08.010. Epub 2011 Dec 24.
10
Reliability of noncontrast-enhancing tumor as a biomarker of IDH1 mutation status in glioblastoma.非增强肿瘤作为胶质母细胞瘤中异柠檬酸脱氢酶1(IDH1)突变状态生物标志物的可靠性
J Clin Neurosci. 2017 May;39:170-175. doi: 10.1016/j.jocn.2017.01.007. Epub 2017 Feb 14.

引用本文的文献

1
A novel amino acid metabolism-related gene signature to predict the overall survival of esophageal squamous cell carcinoma patients.一种用于预测食管鳞状细胞癌患者总生存期的新型氨基酸代谢相关基因特征。
J Thorac Dis. 2024 Jun 30;16(6):3967-3989. doi: 10.21037/jtd-24-818. Epub 2024 Jun 28.
2
A glutamatergic biomarker panel enables differentiating Grade 4 gliomas/astrocytomas from brain metastases.一个谷氨酸能生物标志物组合能够区分4级胶质瘤/星形细胞瘤与脑转移瘤。
Front Oncol. 2024 May 21;14:1335401. doi: 10.3389/fonc.2024.1335401. eCollection 2024.
3
Phenomic Imaging.

本文引用的文献

1
T2-FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower-grade Gliomas: A TCGA/TCIA Project.T2-FLAIR 错配:用于 IDH 和 1p/19q 状态检测的低级别胶质瘤影像学生物标志物:TCGA/TCIA 项目。
Clin Cancer Res. 2017 Oct 15;23(20):6078-6085. doi: 10.1158/1078-0432.CCR-17-0560. Epub 2017 Jul 27.
2
In search of druggable targets for GBM amino acid metabolism.寻找胶质母细胞瘤氨基酸代谢的可成药靶点。
BMC Cancer. 2017 Feb 28;17(1):162. doi: 10.1186/s12885-017-3148-1.
3
Large-scale Radiomic Profiling of Recurrent Glioblastoma Identifies an Imaging Predictor for Stratifying Anti-Angiogenic Treatment Response.
表型组成像
Phenomics. 2023 Nov 3;3(6):597-612. doi: 10.1007/s43657-023-00128-8. eCollection 2023 Dec.
4
The role of branched-chain aminotransferase 1 in driving glioblastoma cell proliferation and invasion varies with tumor subtype.支链氨基酸转氨酶1在驱动胶质母细胞瘤细胞增殖和侵袭中的作用因肿瘤亚型而异。
Neurooncol Adv. 2023 Sep 16;5(1):vdad120. doi: 10.1093/noajnl/vdad120. eCollection 2023 Jan-Dec.
5
The mechanism of branched-chain amino acid transferases in different diseases: Research progress and future prospects.不同疾病中支链氨基酸转移酶的机制:研究进展与未来展望
Front Oncol. 2022 Sep 2;12:988290. doi: 10.3389/fonc.2022.988290. eCollection 2022.
6
Identifying Differential Expression Genes and Prognostic Signature Based on Subventricular Zone Involved Glioblastoma.基于累及脑室下区的胶质母细胞瘤识别差异表达基因和预后特征
Front Genet. 2022 Jul 8;13:912227. doi: 10.3389/fgene.2022.912227. eCollection 2022.
7
Integrated proteomic analysis of low-grade gliomas reveals contributions of 1p-19q co-deletion to oligodendroglioma.低级别胶质瘤的综合蛋白质组学分析揭示了 1p-19q 共缺失对少突胶质细胞瘤的贡献。
Acta Neuropathol Commun. 2022 May 7;10(1):70. doi: 10.1186/s40478-022-01372-1.
8
An overview of branched-chain amino acid aminotransferases: functional differences between mitochondrial and cytosolic isozymes in yeast and human.支链氨基酸氨基转移酶概述:酵母和人线粒体同工酶和胞浆同工酶之间的功能差异。
Appl Microbiol Biotechnol. 2021 Nov;105(21-22):8059-8072. doi: 10.1007/s00253-021-11612-4. Epub 2021 Oct 8.
9
Glutamatergic Mechanisms in Glioblastoma and Tumor-Associated Epilepsy.胶质母细胞瘤和肿瘤相关性癫痫中的谷氨酸能机制。
Cells. 2021 May 17;10(5):1226. doi: 10.3390/cells10051226.
10
Enrichment of branched chain amino acid transaminase 1 correlates with multiple biological processes and contributes to poor survival of IDH1 wild-type gliomas.支链氨基酸转氨酶 1 的富集与多种生物学过程相关,并且与 IDH1 野生型脑胶质瘤患者的不良预后相关。
Aging (Albany NY). 2021 Jan 20;13(3):3645-3660. doi: 10.18632/aging.202328.
复发性胶质母细胞瘤的大规模放射组学分析确定了一种用于分层抗血管生成治疗反应的影像预测指标。
Clin Cancer Res. 2016 Dec 1;22(23):5765-5771. doi: 10.1158/1078-0432.CCR-16-0702. Epub 2016 Oct 10.
4
Assessment of bevacizumab resistance increased by expression of BCAT1 in IDH1 wild-type glioblastoma: application of DSC perfusion MR imaging.IDH1野生型胶质母细胞瘤中BCAT1表达增加对贝伐单抗耐药性的评估:DSC灌注磁共振成像的应用
Oncotarget. 2016 Oct 25;7(43):69606-69615. doi: 10.18632/oncotarget.11901.
5
Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers.肿瘤起源组织决定了KRAS突变驱动型癌症中的支链氨基酸代谢。
Science. 2016 Sep 9;353(6304):1161-5. doi: 10.1126/science.aaf5171.
6
Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.扩散加权磁共振成像与基因组数据的综合分析为胶质母细胞瘤的治疗提供依据。
J Neurooncol. 2016 Sep;129(2):289-300. doi: 10.1007/s11060-016-2174-1. Epub 2016 Jul 8.
7
Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma.异柠檬酸脱氢酶1(IDH1)突变状态对复发性胶质母细胞瘤临床试验结果的影响。
J Neurooncol. 2016 Aug;129(1):147-54. doi: 10.1007/s11060-016-2157-2. Epub 2016 Jun 7.
8
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.2016 年世界卫生组织中枢神经系统肿瘤分类:概述。
Acta Neuropathol. 2016 Jun;131(6):803-20. doi: 10.1007/s00401-016-1545-1. Epub 2016 May 9.
9
Clinical aggressiveness of malignant gliomas is linked to augmented metabolism of amino acids.恶性胶质瘤的临床侵袭性与氨基酸代谢增加有关。
J Neurooncol. 2016 May;128(1):57-66. doi: 10.1007/s11060-016-2073-5. Epub 2016 Feb 27.
10
IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma.异柠檬酸脱氢酶(IDH)突变状态与一种独特的缺氧/血管生成转录组特征相关,该特征在人类胶质瘤中可通过相对脑血容量(rCBV)成像进行非侵入性预测。
Sci Rep. 2015 Nov 5;5:16238. doi: 10.1038/srep16238.